Disease-free survival following high dose or standard dose therapy in patients with amyloidosis

Simple item page
dc.contributor.authorKiel, Patrick J.
dc.contributor.authorTrueg, Anne O.
dc.contributor.authorFerguson, Meagan
dc.contributor.authorBenson, Merrill
dc.contributor.authorAbonour, Rafat
dc.contributor.departmentDepartment of Medicine, IU School of Medicineen_US
dc.date.accessioned2016-03-31T13:51:17Z
dc.date.available2016-03-31T13:51:17Z
dc.date.issued2015
dc.eprint.versionAuthor's manuscripten_US
dc.identifier.citationKiel, P. J., Trueg, A. O., Ferguson, M., Benson, M., & Abonour, R. (2015). Disease-free survival following high dose or standard dose therapy in patients with amyloidosis. British Journal of Haematology. http://doi.org/10.1111/bjh.13656en_US
dc.identifier.urihttps://hdl.handle.net/1805/9106
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.isversionof10.1111/bjh.13656en_US
dc.relation.journalBritish Journal of Haematologyen_US
dc.rightsPublisher Policyen_US
dc.sourceAuthoren_US
dc.subjectbortezomiben_US
dc.subjectmelphalanen_US
dc.subjectautologous haematopoietic cell rescueen_US
dc.subjecttreatment related mortalityen_US
dc.titleDisease-free survival following high dose or standard dose therapy in patients with amyloidosisen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Kiel-2015-Disease-free.pdf
Size:
100.57 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.88 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Open Access Policy Articles
Department of Medicine Works